Ubiquitin signalling in the NF-κB pathway
The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Abstract
The transcription factor NF-kappaB (nuclear factor kappa enhancer binding protein) controls many processes, including immunity, inflammation and apoptosis. Ubiquitination regulates at least three steps in the NF-kappaB pathway: degradation of IkappaB (inhibitor of NF-kappaB), processing of NF-kappaB precursors, and activation of the IkappaB kinase (IKK). Recent studies have revealed several enzymes involved in the ubiquitination and deubiquitination of signalling proteins that mediate IKK activation through a degradation-independent mechanism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By integrating differences in translocation over time, we were able to identify known key negative regulators of the pathway with effects on p65 relaxation that did not score in the initial static screen, including TNFAIP3 (an NF-κB target gene that provides negative feedback by deubiquitinating multiple upstream signaling components) (Chen, 2005), KEAP1 (a ubiquitin ligase involved in degradation”
From Optical Pooled Screens in Human Cells (2019) · cites this paper as Chen, 2005
In the citing paper
“Meanwhile, knockdown of TAB1 was previously shown not to impact IKK activation (Chen, 2005; Wang et al., 2001), consistent with our finding that TAB1 was not detected as a hit in any cell line.”
From Optical Pooled Screens in Human Cells (2019) · cites this paper as Chen, 2005
Citations
Cites
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842 · cited 1×
“Roles of the TAK1 kinase complex in IKK and JNK activation As Tak1 -knockout mice are early embryonic lethal, it has not been possible to determine whether or not this kinase is essential for NF-κB activation in mic”
BackgroundMultiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,752
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125 · cited 1×
“More surprisingly, a key role for ubiquitination in activating protein kinases in the NF-κB pathway through a degradation-independent mechanism has also been discovere”
BackgroundSelf-citationPalombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,096 · cited 1×
“Again, it was through biochemistry that the essential role of ubiquitination in NF-κB activation was reveale”
BackgroundInducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90807-x · Cited by 1,993
TNF-R1 Signaling: A Beautiful Pathway
Chen, G., & Goeddel, D. V. (2002) · Science · doi:10.1126/science.1071924 · Cited by 1,927
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872
Self-citationDe-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856 · cited 1×
“Another DUB that acts in this pathway is A20, an NF-κB-induced protein that inhibits NF-κB in a negative-feedback loo”
BackgroundRegulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb
Jiang, J., & Struhl, G. (1998) · Nature · doi:10.1038/35154 · Cited by 1,735
Research works printed but not linked: 1
- Deng, L. & Chen, Z. Role of Ubiquitin in NF-κB Signaling. 139–160 (Kluwer, Boston, 2003).
Cited by
Items 301–400 of 1,000
Substrate-Trapped Interactors of PHD3 and FIH Cluster in Distinct Signaling Pathways
Rodriguez, J., Pilkington, R., Garcia Munoz, A., Nguyen, L. K., Rauch, N., Kennedy, S., Monsefi, N., Herrero, A., Taylor, C. T., & von Kriegsheim, A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.043 · Cited by 94
“The SCF complex on the other hand is involved in the degradation of signaling proteins such as b-catenin andNFkB (Chen, 2005;Winston et al., 1999).”
BackgroundZhang, C., Li, Z., Jia, X., Wang, K., Tu, Y., Wang, R., Liu, K., Lu, T., & He, C. (2019) · Molecules · doi:10.3390/molecules24050875 · Cited by 99
Role and mechanisms of the NF-ĸB signaling pathway in various developmental processes
Liu, P., Li, Y., Wang, W., Bai, Y., Jia, H., Yuan, Z., & Zhonghua, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113513 · Cited by 99
Jin, X., Jin, H. R., Jung, H. S., Lee, S. J., Lee, J.-H., & Lee, J. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.129551 · Cited by 94
Molecular basis of hypohidrotic ectodermal dysplasia: an update
Trzeciak, W. H., & Koczorowski, R. (2016) · Journal of Applied Genetics · doi:10.1007/s13353-015-0307-4 · Cited by 91
“TAK1 probably contains other subunits such as Cdc37 and hsp90 (Chen 2005; Israel 2010).”
BackgroundDenis, N. J., Vasilescu, J., Lambert, J., Smith, J. C., & Figeys, D. (2007) · PROTEOMICS · doi:10.1002/pmic.200600410 · Cited by 94
Dissecting the ubiquitin pathway by mass spectrometry
Xu, P., & Peng, J. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.09.004 · Cited by 94
Lobry, C., Lopez, T. E., Israël, A., & Weil, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606982104 · Cited by 101
Inomata, M., Niida, S., Shibata, K.-I., & Into, T. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0819-y · Cited by 89
Regulation of pluripotency and differentiation by deubiquitinating enzymes
Suresh, B., Lee, J., Kim, S., & Ramakrishna, S. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.53 · Cited by 100
Arnold, M. M., & Patton, J. T. (2010) · Journal of Virology · doi:10.1128/jvi.01801-10 · Cited by 105
Qu, F., Gao, H., Zhu, S., Shi, P., Zhang, Y., Liu, Y., Jallal, B., Yao, Y., Shi, Y., & Qian, Y. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00268-12 · Cited by 87
Tokunaga, F., & Iwaï, K. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.01.011 · Cited by 105
Wang, Y., Park, N.-Y., Jang, Y., Ma, A. I., & Jiang, Q. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403149 · Cited by 91
Hydrogen peroxide and redox modulation sensitize primary mouse hepatocytes to TNF-induced apoptosis
Han, D., Hanawa, N., Saberi, B., & Kaplowitz, N. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.05.002 · Cited by 97
Marine natural products as targeted modulators of the transcription factor NF-κB
Folmer, F., Jaspars, M., Dicato, M. A., & Diederich, M. F. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.044 · Cited by 100
Rhabdovirus Evasion of the Interferon System
Rieder, M., & Conzelmann, K. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0068 · Cited by 99
“TRAF6, like TRAF3 in RIG-I signaling , is subject to K63-linked ubiquitinylation, which is crucial for IFN-inducing signal transduction (Chen 2005).”
Phylogeny of the TRAF/MATH Domain
Zapata, J. M., Martínez-García, V., & Lefebvre, S. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_1 · Cited by 103
Wang, X. H., Zhang, L., Mitch, W. E., LeDoux, J. M., Hu, J., & Du, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041707 · Cited by 89
Zhong, J., Wang, H., Chen, W., Sun, Z., Chen, J., Xu, Y., Weng, M., Shi, Q., Ma, D., & Miao, C. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.102 · Cited by 100
Therapeutic potential of ginger against COVID-19: Is there enough evidence?
Jafarzadeh, A., Jafarzadeh, S., & Nemati, M. (2021) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2021.10.001 · Cited by 109
NF-κB-related genetic diseases
Courtois, G., & Smahi, A. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401841 · Cited by 100
Watanabe, T., Asano, N., Meng, G., Yamashita, K., Arai, Y., Sakurai, T., Kudo, M., Fuss, I. J., Kitani, A., Shimosegawa, T., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.19 · Cited by 89
Jiang, W. J., Yin, J., Han, M., He, W., Zhao, Y., Hu, J., Wang, M., Wang, S., Xu, J., Deng, C., et al. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s518155 · Cited by 88
Interleukin-1β–Induced Disruption of Barrier Function in Cultured Human Corneal Epithelial Cells
Kimura, K., Teranishi, S., & Nishida, T. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2606 · Cited by 88
TRAF6 distinctively mediates MyD88- and IRAK-1-induced activation of NF-κB
Muroi, M., & Tanamoto, K.-I. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0907629 · Cited by 83
Tang, H., Park, S., Sun, S., Trumbly, R. J., Ren, G., Tsung, E. F., & Yeung, K. C. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.12.051 · Cited by 100
The ubiquitin-proteasome system in colorectal cancer
Voutsadakis, I. A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.06.007 · Cited by 90
“In addition, NF-κB family members p100 and p105 are cleaved to their active counterparts p52 and p50 respectively by the proteasome [34].”
Dai, Y., Lawrence, T. S., & Xu, L. (2009) · PubMed · Cited by 87
FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma
Romano, S., Xiao, Y., Nakaya, M., D'Angelillo, A., Chang, M., Jin, J., Hausch, F., Masullo, M., Feng, X., Romano, M. F., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv615 · Cited by 82
Wang, Y.-T., Liu, T.-Y., Shen, C.-H., Lin, S., Hung, C.-C., Hsu, L.-C., & Chen, G. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110354 · Cited by 91
Deubiquitylating enzymes and disease
Singhal, S., Taylor, M. C., & Baker, R. T. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s3 · Cited by 93
Negative regulation of NF-κB activity by brain-specific TRIpartite Motif protein 9
Shi, M., Cho, H., Inn, K., Yang, A., Zhao, Z., Liang, Q., Versteeg, G. A., Amini‐Bavil‐Olyaee, S., Wong, L.-Y., Zloković, B. V., et al. (2014) · Nature Communications · doi:10.1038/ncomms5820 · Cited by 98
Tan, K. S., Chen, Y., Lim, Y.-C., Tan, G.-Y. G., Liu, Y., Lim, Y.-T., MacAry, P., & Gan, Y.-H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902663 · Cited by 82
“Modifications of two signaling intermediates by ubiquitination play critical roles in TLR-mediated NF-kB activation (41).”
BackgroundInhibitory effects of flavonoids on TNF-α-induced IL-8 gene expression in HEK 293 cells
Lee, S.-H., Kim, Y.-J., Kwon, S., Lee, Y., Choi, S.-Y., Park, J., & Kwon, H. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.5.265 · Cited by 85
“nucleus, where it activates various genes (11, 20).”
BackgroundZheng, Z., Li, H., Zhang, Z., Meng, J., Mao, D., Bai, B., Lu, B., Mao, P., Hu, Q., & Wang, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100285 · Cited by 93
Glaucoma and neuroinflammation: An overview
Quaranta, L., Bruttini, C., Micheletti, E., Konstas, A. G. P., Michelessi, M., Oddone, F., Katsanos, A., Sbardella, D., Angelis, G. D., & Riva, I. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2021.02.003 · Cited by 88
Regulation of the RSP5 Ubiquitin Ligase by an Intrinsic Ubiquitin-binding Site
French, M. E., Kretzmann, B. R., & Hicke, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901106200 · Cited by 81
Gatot, J.-S., Gioia, R., Chau, T.-L., Patrascu, F., Warnier, M., Close, P., Chapelle, J.-P., Muraille, E., Brown, K., Siebenlist, U., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701690200 · Cited by 82
Li, Y., Deng, L., Zhao, X., Li, B., Ren, D., Yu, L., Pan, H., Gong, Q., Song, L., Zhou, X., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5144 · Cited by 88
Yue, S., Chen, Y., & Cheng, S. Y. (2008) · Oncogene · doi:10.1038/onc.2008.403 · Cited by 88
Harhaj, N. S., Sun, S., & Harhaj, E. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m611031200 · Cited by 85
Patented small molecule inhibitors in the ubiquitin proteasome system
Guédat, P., & Colland, F. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s14 · Cited by 90
McCoy, C. E., Carpenter, S., Pålsson-McDermott, E. M., Gearing, L. J., & O'Neill, L. A. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709731200 · Cited by 82
Wu, Z., & Miyamoto, S. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.127 · Cited by 94
Wicovsky, A., Henkler, F., Salzmann, S., Scheurich, P., Kneitz, C., & Wajant, H. (2009) · Oncogene · doi:10.1038/onc.2009.29 · Cited by 99
“It has been shown for TRAF2 and TRAF6 that the crucial role of their RING domain in NFkB and JNK activation is related to their capability to act as E3 ubiquitin ligases (Chen 2005).”
BackgroundLim, J. H., Jono, H., Koga, T., Woo, C.-H., Ishinaga, H., Bourne, P. A., Xu, H., Ha, U., Xu, H., & Li, J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001032 · Cited by 93
Glutamine-Directed Migration of Cancer-Activated Fibroblasts Facilitates Epithelial Tumor Invasion
Mestre‐Farrera, A., Bruch‐Oms, M., Peña, R., Rodríguez-Morató, J., Alba‐Castellón, L., Comerma, L., Quintela-Fandiño, M., Duñach, M., Baulida, J., Pozo, Ó. J., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-0622 · Cited by 84
Signaling pathways activated by microorganisms
Takeuchi, O., & Akira, S. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.006 · Cited by 94
Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation
Khoury, J., Ibla, J. C., Neish, A. S., & Colgan, S. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30049 · Cited by 81
TRAF6 Restricts p53 Mitochondrial Translocation, Apoptosis, and Tumor Suppression
Zhang, X., Li, C., Zhang, L., Wu, C., Han, L., Jin, G., Rezaeian, A. H., Han, F., Liu, C., Xu, C. S., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.002 · Cited by 81
“TRAF6 is shown to be involved in the innate immune response and tumorigenesis by regulating TLR4/IL-1R and growth factorinduced AKT signaling (Chen, 2005; Yang et al., 2009, 2010a, 2010b).”
BackgroundFeng, Y., Duan, T., Du, Y., Jin, S., Wang, M., Cui, J., & Wang, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-12573-3 · Cited by 80
Zucchelli, S., Marcuzzi, F., Codrich, M., Agostoni, E., Vilotti, S., Biagioli, M., Pinto, M., Carnemolla, A., Santoro, C., Gustincich, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.187591 · Cited by 77
Plant TRAF Proteins Regulate NLR Immune Receptor Turnover
Huang, S., Chen, X., Zhong, X., Li, M., Ao, K., Huang, J., & Li, X. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.005 · Cited by 87
Regulation and dysregulation of tumor necrosis factor receptor-1
Puimège, L., Libert, C., & Hauwermeiren, F. V. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.03.004 · Cited by 85
Adaptors in Toll-Like Receptor Signaling and their Potential as Therapeutic Targets
Ve, T., Gay, N. J., Mansell, A. S., Kobe, B., & Kellie, S. (2012) · Current Drug Targets · doi:10.2174/138945012803530260 · Cited by 85
Whitehurst, C. B., Ning, S., Bentz, G. L., Dufour, F., Gershburg, E., Shackelford, J., Langelier, Y., & Pagano, J. S. (2009) · Journal of Virology · doi:10.1128/jvi.02195-08 · Cited by 78
Charting the NF-κB Pathway Interactome Map
Tieri, P., Termanini, A., Bellavista, E., Salvioli, S., Capri, M., & Franceschi, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032678 · Cited by 73
miR-892b Silencing Activates NF-κB and Promotes Aggressiveness in Breast Cancer
Jiang, L., Yu, L., Zhang, X., Lei, F., Wang, L., Liu, X., Wu, S., Zhu, J., Wu, G., Cao, L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1770 · Cited by 77
Jin, W., Reiley, W. W., Lee, A. J., Wright, A., Wu, X., Zhang, M., & Sun, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609952200 · Cited by 85
Raetzsch, C. F., Brooks, N. L., Alderman, J. M., Moore, K. S., Hosick, P. A., Klebanov, S., Akira, S., Bear, J. E., Baldwin, A. S., Mackman, N., et al. (2009) · Hepatology · doi:10.1002/hep.22999 · Cited by 74
Jang, K. W., Lee, K. H., Kim, S. H., Jin, T., Choi, E. Y., Jeon, H. J., Kim, E., Han, Y. S., & Chung, J. H. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23292 · Cited by 82
“CHIP INTERACTS WITH TRAF2 AND INDUCES ITS UBIQUITINATION TRAFs regulate the classical and alternative pathways of NF-kB activation, with TRAF2 and TRAF6 playing positive roles in the activation of the NF-kB pathway [Chen, 2005].”
BackgroundThe Effect of Resveratrol on a Cell Model of Human Aging
STEFANI, M., MARKUS, M. A., LIN, R. C. Y., PINESE, M., DAWES, I. W., & MORRIS, B. J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1396.001 · Cited by 75
Kundu, M., & Basu, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687962 · Cited by 79
“TNF receptor-associated factors (TRAFs), which then undergo K63-linkedubiquitination to activate the IkBkinase (IKK) complex (25).”
BackgroundZhang, J., Wang, S., Wang, K., & Zheng, C. (2013) · Medical Microbiology and Immunology · doi:10.1007/s00430-013-0295-0 · Cited by 74
Voutsadakis, I. A. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00032.x · Cited by 74
“NF- B is in reality a family of related proteins that include REL-A (p65), REL-B, c-REL, p50 and p52, which bind their cognate DNA sequences as dimers [141].”
BackgroundNew ATPase regulators—p97 goes to the PUB
Madsen, L., Seeger, M., Semple, C. A. M., & Hartmann‐Petersen, R. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.05.017 · Cited by 73
Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases
Guo, B., & Li, Z. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00242 · Cited by 73
“NF-κB is a homo or heterodimeric transcription factor that binds to κB sites in the promoters of a large number of genes involved in cell survival, inflammation, and immune responses (Senftleben and Karin, 2002; Chen, 2005).”
BackgroundElia, A., Constantinou, C., & Clemens, M. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210678 · Cited by 79
“The loss of IkB allows NF-kB to enter the nucleus and stimulate the transcription of genes with antiapoptotic activity (Graham and Gibson, 2005).”
BackgroundInfluentialYan, D., Wang, X., Luo, L., Cao, X., & Ge, B. (2012) · Nature Immunology · doi:10.1038/ni.2417 · Cited by 83
Martínez‐Forero, I., Azpilikueta, A., Bolaños, E., Nistal‐Villán, E., Palazón, A., Teijeira, Á., Pérez-Chacón, G., Morales‐Kastresana, A., Murillo, O., Jure‐Kunkel, M., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203010 · Cited by 75
Ding, Y., Song, Y., Wu, Y., He, H., Yu, T., Hu, Y., Zhang, D., Jiang, H., Yu, K., Li, X., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0061-3 · Cited by 75
Gan, N., Nakayasu, E. S., Hollenbeck, P. J., & Luo, Z. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0282-8 · Cited by 77
Abnormal NF-κB Function Characterizes Human Type 1 Diabetes Dendritic Cells and Monocytes
Mollah, Z. U. A., Pai, S., Moore, C., O’Sullivan, B., Harrison, M., Peng, J., Phillips, K. S., Prins, J. B., Cardinal, J. W., & Thomas, R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3166 · Cited by 80
Caspase-8 and c-FLIPL Associate in Lipid Rafts with NF-κB Adaptors during T Cell Activation
Misra, R. S., Russell, J. Q., Koenig, A., Hinshaw-Makepeace, J. A., Wen, R., Wang, D., Huo, H., Littman, D. R., Ferch, U., Ruland, J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610610200 · Cited by 86
Takami, Y., Nakagami, H., Morishita, R., Katsuya, T., Cui, T., Ichikawa, T., Saito, Y., Hayashi, H., Kikuchi, Y., Nishikawa, T., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.142505 · Cited by 73
Hamidi, A., von Bülow, V., Hamidi, R., Winssinger, N., Barluenga, S., Heldin, C., & Landström, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.285122 · Cited by 77
Heterologous SUMO-2/3-Ubiquitin Chains Optimize IκBα Degradation and NF-κB Activity
Aillet, F., Lopitz‐Otsoa, F., Egaña, I., Hjerpe, R., Fraser, P. E., Hay, R. T., Rodríguez, M. S., & Lang, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051672 · Cited by 80
Allen, C. T., Saigal, K., Nottingham, L. K., Arun, P., Chen, Z., & Waes, C. V. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4470 · Cited by 72
Self-citationEpigenetic modifications in rheumatoid arthritis
Strietholt, S., Maurer, B., Peters, M. A., Pap, T., & Gay, S. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2500 · Cited by 77
Wang, W., Chen, J., Yu, X., & Lan, H.-Y. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72663 · Cited by 75
Oxidative Inactivation of the Proteasome in Retinal Pigment Epithelial Cells
Fernandes, A. F., Zhou, J., Zhang, X., Bian, Q., Sparrow, J., Taylor, A., Pereira, P., & Shang, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800268200 · Cited by 68
Vialinin A is a ubiquitin-specific peptidase inhibitor
Okada, K., Ye, Y. Q., Taniguchi, K., Yoshida, A., Akiyama, T., Yoshioka, Y., Onose, J., Koshino, H., Takahashi, S., Yajima, A., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.05.093 · Cited by 71
Chang, S.-J., Hsiao, J., Sonnberg, S., Chiang, C.-T., Yang, M.-H., Tzou, D. M., Mercer, A. A., & Chang, W. (2009) · Journal of Virology · doi:10.1128/jvi.01835-08 · Cited by 71
“All of these signals are transmitted through different intracellular adaptors and converged on activation of the IKK complex that phosphorylates IB and promotes the ubiquitination of IB and its subsequent degradation in proteasomes ( 9 ).”
BackgroundInfluentialHuman T-Cell Lymphotropic Virus: A Model of NF-κB-Associated Tumorigenesis
Qu, Z., & Xiao, G. (2011) · Viruses · doi:10.3390/v3060714 · Cited by 74
Genetic and Expression Aberrations of E3 Ubiquitin Ligases in Human Breast Cancer
Chen, C., Seth, A. K., & Aplin, A. E. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0182 · Cited by 81
TRAF2 is an NF-κB-activating oncogene in epithelial cancers
Shen, R. R., Zhou, A. Y., Kim, E., O’Connell, J. T., Hägerstrand, D., Beroukhim, R., & Hahn, W. C. (2013) · Oncogene · doi:10.1038/onc.2013.543 · Cited by 83
Kato, K., Lillehoj, E. P., Park, Y. S., Umehara, T., Hoffman, N. E., Madesh, M., & Kim, K. C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102405 · Cited by 70
miR-204-5p Represses Bone Metastasis via Inactivating NF-κB Signaling in Prostate Cancer
Wa, Q., Huang, S., Pan, J., Tang, Y., He, S., Fu, X., Peng, X., Chen, X., Yang, C., Ren, D., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.09.008 · Cited by 76
Cytosol as battleground: ubiquitin as a weapon for both host and pathogen
Collins, C. A., & Brown, E. J. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.002 · Cited by 76
Toll-Like Receptors in Angiogenesis
Grote, K., Schütt, H., & Schieffer, B. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.92 · Cited by 77
Necroptosis: Biochemical, Physiological and Pathological Aspects
Dunai, Z. A., Bauer, P. I., & Mihalik, R. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-011-9433-4 · Cited by 79
“Phosphorylated IkB is target for polyubiquitilation and subsequent proteasomal degradation thereby contributes to the release of NFkB that translocates to the nucleus and mediates prosurvival gene expressions and also the activation of MAPK cascade [26, 27].”
BackgroundStat2 stability regulation: an intersection between immunity and carcinogenesis
Lee, C., An, H., Cho, E. S., Kang, H. C., Lee, J. Y., Lee, H. S., & Cho, Y. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00506-6 · Cited by 74
Melatonin as a proteasome inhibitor. Is there any clinical evidence?
Vriend, J. P., & Reiter, R. J. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.08.024 · Cited by 72
“Degradation of the NF-κB inhibitor, IκK, by the proteasome results in activation of NF-κB (Traenckner et al., 1994; Chen, 2005; Gilmore, 2006; Brasier, 2006; Perkins, 2007; Skaug et al., 2009).”
BackgroundCheung, H. H., Plenchette, S., Kern, C. J., Mahoney, D. J., & Korneluk, R. G. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-01-0107 · Cited by 79
“For instance, in vitro, the E3 ligase of cIAP2 facilitates the K63polyubiquitination of RIP1 (Wu et al., 2006), a key event in tumor necrosis factor (TNF)- –induced NF- B activation (Chen, 2005).”
The current status and future directions of myxoma virus, a master in immune evasion
Spiesschaert, B., McFadden, G., Hermans, K., Nauwynck, H., & de Walle, G. R. V. (2011) · Veterinary Research · doi:10.1186/1297-9716-42-76 · Cited by 68
IL-17 induces macrophages to M2-like phenotype via NF-κB
Shen, J., Sun, X., Pan, B., Cao, S., Cao, J., Che, D., Liu, F., Zhang, S., & Yu, Y. (2018) · Cancer Management and Research · doi:10.2147/cmar.s174899 · Cited by 74
Lee, T. V., Ding, T., Chen, Z., Rajendran, V., Scherr, H., Lackey, M., Bolduc, C., & Bergmann, A. (2008) · Development · doi:10.1242/dev.011288 · Cited by 67
“In addition, non-traditional functions of ubiquitination, which do not target proteins for proteolysis, have been reported (Chen, 2005; Mukhopadhyay and Riezman, 2007; Welchman et al., 2005).”
BackgroundSelf-citationJarvis, M. A., Borton, J. A., Keech, A. M., Wong, J. W., Britt, W. J., Magun, B. E., & Nelson, J. A. (2006) · Journal of Virology · doi:10.1128/jvi.00060-06 · Cited by 68
S-Glutathionylation of the Rpn2 Regulatory Subunit Inhibits 26 S Proteasomal Function
Zmijewski, J. W., Banerjee, S., & Abraham, E. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028902 · Cited by 70
Metadata
- Authors
- Chen, Z. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Chen, Zhijian J.
- ORCID
- Chen, Zhijian J.
- Venue
- Nature Cell Biology
- Published
- 2005-08
- Volume
- 7
- Issue
- 8
- Pages
- 758-765
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2056402897
- Cited by
- 1,184
- References
- 84
- Citations by year
- 2026: 21 · 2025: 20 · 2024: 23 · 2023: 34 · 2022: 34 · 2021: 46 · 2020: 31 · 2019: 38 · 2018: 45 · 2017: 49 · 2016: 41 · 2015: 50 · 2014: 64 · 2013: 60 · 2012: 62
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- National Institute of General Medical Sciences (R01GM063692)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NF-κB signaling, ubiquitination, deubiquitination, IκB degradation, inflammation, immunity, apoptosis
- MeSH terms
- MAP Kinase Kinase Kinase 7, Animals, Humans, Lymphocyte Activation, Models, Biological, Protein Kinases, Signal Transduction, NF-kappa B, Protein Serine-Threonine Kinases, I-kappa B Proteins, Mitogen-Activated Protein Kinase Kinases, MAP Kinase Kinase Kinases, Ubiquitin, Ubiquitin-Protein Ligases, TNF Receptor-Associated Factor 2, TNF Receptor-Associated Factor 6, JNK Mitogen-Activated Protein Kinases, MAP Kinase Kinase 4, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.